Alpine Bank Wealth Management Decreases Stock Holdings in The Clorox Company $CLX

Alpine Bank Wealth Management lessened its holdings in The Clorox Company (NYSE:CLX) by 14.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,785 shares of the company’s stock after selling 460 shares during the period. Alpine Bank Wealth Management’s holdings in Clorox were worth $334,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Albion Financial Group UT lifted its holdings in shares of Clorox by 0.3% in the second quarter. Albion Financial Group UT now owns 34,889 shares of the company’s stock valued at $4,189,000 after purchasing an additional 115 shares in the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of Clorox by 26.4% in the second quarter. V Square Quantitative Management LLC now owns 4,442 shares of the company’s stock valued at $533,000 after purchasing an additional 929 shares in the last quarter. TBH Global Asset Management LLC lifted its holdings in shares of Clorox by 47.2% in the second quarter. TBH Global Asset Management LLC now owns 3,000 shares of the company’s stock valued at $360,000 after purchasing an additional 962 shares in the last quarter. Brown Lisle Cummings Inc. lifted its holdings in shares of Clorox by 4.3% in the second quarter. Brown Lisle Cummings Inc. now owns 2,136 shares of the company’s stock valued at $256,000 after purchasing an additional 89 shares in the last quarter. Finally, ST Germain D J Co. Inc. lifted its holdings in shares of Clorox by 5.5% in the second quarter. ST Germain D J Co. Inc. now owns 4,306 shares of the company’s stock valued at $517,000 after purchasing an additional 225 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock opened at $124.44 on Monday. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The company has a 50 day moving average price of $123.53 and a 200 day moving average price of $130.23. The firm has a market capitalization of $15.22 billion, a price-to-earnings ratio of 19.09, a price-to-earnings-growth ratio of 1.00 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same quarter in the prior year, the business posted $1.82 earnings per share. Clorox’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox’s dividend payout ratio is 76.07%.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.57% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on CLX shares. Jefferies Financial Group reduced their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. Citigroup reaffirmed a “neutral” rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Barclays reduced their price objective on shares of Clorox from $129.00 to $119.00 and set an “underweight” rating on the stock in a research note on Tuesday, July 15th. Wells Fargo & Company lowered their target price on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research note on Thursday. Finally, UBS Group reduced their price target on Clorox from $150.00 to $134.00 and set a “neutral” rating on the stock in a research note on Thursday, July 17th. One equities research analyst has rated the stock with a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and an average price target of $141.73.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.